Texas 2023 - 88th Regular

Texas Senate Bill SB2535

Voted on by Senate
 
Out of House Committee
 
Voted on by House
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to the use of prescription glucagon medication on public and private school campuses.

Impact

The legislation is expected to significantly impact how diabetes care is managed in schools. By authorizing unlicensed diabetes care assistants to carry glucagon, the bill aims to increase the responsiveness to diabetes-related emergencies. Schools will be required to adopt policies regarding glucagon medication, promoting a standardized approach to health management in educational settings. Moreover, the bill emphasizes the importance of physician and pharmacist involvement in ensuring that glucagon is readily available, thereby outlining a collaborative health care approach that integrates education and health services.

Summary

SB2535 aims to facilitate the use of prescription glucagon medications in public and private schools across Texas. The bill expands certain provisions to allow unlicensed diabetes care assistants to carry undesignated glucagon medications, which are critical in treating severe hypoglycemia. It also mandates that each school district develop a policy regarding the storage, administration, and disposal of glucagon medication, ensuring it is both secure and accessible. The intended outcome is to enhance the safety and health response capabilities within school environments, especially for students with diabetes.

Sentiment

The sentiment surrounding SB2535 appears to be predominantly positive, particularly among advocates for children's health and those concerned about diabetes management in schools. Supporters view the bill as a crucial step towards safeguarding the health of students with diabetes by enabling timely medical intervention. However, there may be concerns regarding the implications of allowing unlicensed personnel to administer medication, which could lead to debates about ensuring sufficient training and oversight.

Contention

While SB2535 is largely framed as a supportive measure for students with diabetes, notable points of contention may arise surrounding the responsibilities of school personnel. Critics could argue that placing the burden of medication management on unlicensed assistants might result in potential safety risks if these individuals are not properly trained. Additionally, there might be discussions regarding the financial implications for schools in developing and implementing the required policies, particularly related to the procurement of glucagon and associated training programs.

Texas Constitutional Statutes Affected

Health And Safety Code

  • Chapter 168. Care Of Students With Diabetes
    • Section: New Section
    • Section: 004

Occupations Code

  • Chapter 168. Regulation Of Pain Management Clinics
    • Section: New Section
  • Chapter 157. Authority Of Physician To Delegate Certain Medical Acts
    • Section: New Section

Companion Bills

TX HB2891

Identical Relating to the use of glucagon medication on certain public and private school campuses.

Previously Filed As

TX HB2891

Relating to the use of glucagon medication on certain public and private school campuses.

TX HB350

Relating to the use of glucagon medication on certain public and private school campuses.

TX HB2243

Relating to the use of prescription asthma medicine on public and private school campuses.

TX SB1665

Relating to the use of prescription asthma medicine on public and private school campuses.

TX HB440

Education; authorize public and private schools to stock a supply of undesignated ready-to-use glucagon

TX SB92

Glucagon for Schools Act

TX HB920

Relating to the use of medication designated for treatment of respiratory distress on public and private school campuses.

TX SB195

Glucagon for Schools Act

TX SB293

Creating the Glucagon for Schools Act

TX LD867

An Act Regarding Undesignated Ready-to-use Glucagon Rescue Therapies in Schools

Similar Bills

NJ A4280

Extends permission to administer blood glucose tests to EMTs.

NJ S3278

Extends permission to administer glucagon and blood glucose tests to EMTs.

NJ A5066

Concerns administration of ready-to-use undesignated glucagon rescue therapy in public schools.

NJ A1882

Concerns administration of ready-to-use undesignated glucagon rescue therapy in public schools.

FL H0597

Diabetes Management in Schools

WV SB92

Glucagon for Schools Act

IL SB2235

STU DIABETES-GLUCAGON SUPPLY

DC B25-0226

Access to Emergency Albuterol and Glucagon Amendment Act of 2023 (now known as "Access to Emergency Medications Amendment Act of 2023")